 | Up a level |
Francis, PA; Pagani, O; Fleming, GF; Walley, BA; Colleoni, M; Láng, I; Gómez, HL; Tondini, C; Ciruelos, E; Burstein, HJ; Bonnefoi, HR; Bellet, M; Martino, S; Geyer, Jr. CE; Goetz, MP; Stearns, V; Pinotti, G; Puglisi, F; Spazzapan, S; Climent, MA; ... (2018). Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. New England journal of medicine NEJM, 379(2), pp. 122-137. Massachusetts Medical Society MMS 10.1056/NEJMoa1803164
Bernhard, J; Zahrieh, D; Castiglione-Gertsch, M; Hürny, C; Gelber, RD; Forbes, JF; Murray, E; Collins, J; Aebi, S; Thürlimann, B; Price, KN; Goldhirsch, A; Coates, AS; International, Breast Cancer Study Group Trial VIII (2007). Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. Journal of clinical oncology, 25(3), pp. 263-70. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.5393
Mauriac, L; Keshaviah, A; Debled, M; Mouridsen, H; Forbes, JF; Thürlimann, B; Paridaens, R; Monnier, A; Láng, I; Wardley, A; Nogaret, JM; Gelber, RD; Castiglione-Gertsch, M; Price, KN; Coates, AS; Smith, I; Viale, G; Rabaglio, M; Zabaznyi, N; Goldhirsch, A; ... (2007). Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Annals of oncology, 18(5), pp. 859-67. Oxford: Oxford University Press 10.1093/annonc/mdm001
Colleoni, M; Gelber, S; Goldhirsch, A; Aebi, S; Castiglione-Gertsch, M; Price, KN; Coates, AS; Gelber, RD; International, Breast Cancer Study Group (2006). Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. Journal of clinical oncology, 24(9), pp. 1332-41. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.0783
Basser, RL; O'Neill, A; Martinelli, G; Green, MD; Peccatori, F; Cinieri, S; Coates, AS; Gelber, RD; Aebi, S; Castiglione-Gertsch, M; Viale, G; Price, KN; Goldhirsch, A; International, Breast Cancer Study Group (2006). Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95. Journal of clinical oncology, 24(3), pp. 370-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.5196
Rudenstam, CM; Zahrieh, D; Forbes, JF; Crivellari, D; Holmberg, SB; Rey, P; Dent, D; Campbell, I; Bernhard, J; Price, KN; Castiglione-Gertsch, M; Goldhirsch, A; Gelber, RD; Coates, AS; International, Breast Cancer Study Group (2006). Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. Journal of clinical oncology, 24(3), pp. 337-44. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.01.5784
Regan, MM; Viale, G; Mastropasqua, MG; Maiorano, E; Golouh, R; Carbone, A; Brown, B; Suurküla, M; Langman, G; Mazzucchelli, L; Braye, S; Grigolato, P; Gelber, RD; Castiglione-Gertsch, M; Price, KN; Coates, AS; Goldhirsch, A; Gusterson, B; International, Breast Cancer Study Group (2006). Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Journal of the National Cancer Institute JNCI, 98(21), pp. 1571-81. Cary, N.C.: Oxford University Press 10.1093/jnci/djj415
Pestalozzi, BC; Zahrieh, D; Price, KN; Holmberg, SB; Lindtner, J; Collins, J; Crivellari, D; Fey, MF; Murray, E; Pagani, O; Simoncini, E; Castiglione-Gertsch, M; Gelber, RD; Coates, AS; Goldhirsch, A; International, Breast Cancer Study Group (IBCSG) (2006). Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Annals of oncology, 17(6), pp. 935-44. Oxford: Oxford University Press 10.1093/annonc/mdl064
Gianni, L; Panzini, I; Li, S; Gelber, RD; Collins, J; Holmberg, SB; Crivellari, D; Castiglione-Gertsch, M; Goldhirsch, A; Coates, AS; Ravaioli, A; International, Breast Cancer Study Group (IBCSG) (2006). Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials. Cancer, 106(3), pp. 505-13. New York, N.Y.: John Wiley & Sons 10.1002/cncr.21651
